The main ingredient of Salvo is Mesalazine, which is mainly used in the treatment of ulcerative colitis, Crohn’s bowel disease and other diseases. Its hazards mainly refer to the adverse reactions of the medication and the related toxicity. Rare adverse reactions are known to involve the digestive system and the central system; very rare ones also involve the blood system and the immune system.
1. Rare adverse reactions: including abdominal discomfort, nausea and vomiting, diarrhea and flatulence and other digestive adverse reactions, as well as dizziness, headache and other central nervous system symptoms.
2. Very rare adverse reactions: allergic reactions of the immune system such as allergic rash, drug fever, bronchospasm, etc., aplastic anemia of the blood system, granulocyte deficiency and other adverse reactions, as well as acute and chronic interstitial nephritis and renal dysfunction such as renal dysfunction.
3. Toxicology studies: Mesalazine has been found to be nephrotoxic in toxicology studies with high dose repeated oral administration, but the clinical relevance of these findings is unclear.
If patients experience adverse reactions when using mesalazine enteric-coated tablets, they should go to the hospital in time to identify the cause of the disease, standardize the treatment, use the drugs under the guidance of the doctor and avoid unauthorized use of drugs.